Start of Coverage: 10-01-2006
We are fine tuning our model post 3Q, resulting in a new Dec-24 Price Target of €20.9/share (€19.9/share), with estimates 2-3% higher for revenues and EBITDA
Analyst: Borja Olcese
e-mail: borja.olcese@jpmorgan.com
| Analyst | Price target | Recommendation | Date |
| Borja Olcese | 20.90 € | Underweight | 2 Nov 2023 |
| Borja Olcese | 19.90 € | Underweight | 4 Oct 2023 |
| Borja Olcese | 20.80 € | Underweight | 5 Sep 2023 |
| Borja Olcese | 23.70 € | Neutral | 1 Aug 2023 |
| Borja Olcese | 24.40 € | Neutral | 12 Jul 2023 |
| Borja Olcese | 24.80 € | Neutral | 7 Jun 2023 |
| Borja Olcese | 24.10 € | Neutral | 3 May 2023 |
| Borja Olcese | 24.80 € | Neutral | 29 Mar 2023 |
| Borja Olcese | 25.00 € | Neutral | 13 Jan 2023 |
| Borja Olcese | 24.80 € | Neutral | 3 Jan 2023 |
| Borja Olcese | 24.10 € | Neutral | 5 Dec 2022 |
| Borja Olcese | 21.00 € | Overweight | 26 Oct 2022 |
| Borja Olcese | 23.10 € | Overweight | 4 Oct 2022 |
| Borja Olcese | 27.00 € | Overweight | 4 Jul 2022 |
| Borja Olcese | 25.00 € | Overweight | 15 Mar 2022 |
| Borja Olcese | 23.50 € | Overweight | 3 Dec 2021 |
| Borja Olcese | 20.00 € | Overweight | 28 Oct 2021 |
| Borja Olcese | 19.00 € | Overweight | 6 Aug 2021 |
| Borja Olcese | 18.00 € | Overweight | 4 May 2021 |
| Borja Olcese | 17.00 € | Overweight | 8 Mar 2021 |
| Borja Olcese | 17.00 € | Overweight | 16 Feb 2021 |
| Estelle Weingrod | 18.00 € | Overweight | 19 May 2020 |
| Estelle Weingrod | 19.50 € | Overweight | 14 Jan 2020 |
| Borja Olcese | 19.00 € | Overweight | 12 Jul 2019 |
| Borja Olcese | 18.50 € | Overweight | 16 May 2019 |
| Estelle Weingrod | 18.50 € | Overweight | 27 Jul 2018 |
| Estelle Weingrod | 19.50 € | Overweight | 25 Jul 2018 |
| Estelle Weingrod | 21.00 € | Overweight | 4 Jan 2018 |
| Estelle Weingrod | 19.50 € | Overweight | 29 Jun 2017 |
| Estelle Weingrod | 18.00 € | Overweight | 15 Feb 2017 |
| Estelle Weingrod | 17.50 € | Overweight | 6 Oct 2016 |
| Estelle Weingrod | 16.50 € | Overweight | 28 Apr 2016 |
| Borja Olcese | 15.00 € | Overweight | 30 Jul 2015 |
| Borja Olcese | 13.40 € | Overweight | 14 Apr 2015 |
| Jaime Vasquez | 10.00 € | Overweight | 14 Jan 2015 |
| Jaime Vasquez | 8.30 € | Neutral | 17 Nov 2014 |
| Jaime Vasquez | 7.70 € | Neutral | 30 Oct 2014 |
| Jaime Vasquez | 8.50 € | Neutral | 6 Oct 2014 |
| Jaime Vasquez | 11.00 € | Neutral | 29 Jul 2014 |
| Jaime Vasquez | 12.00 € | Neutral | 26 Feb 2014 |
| Jaime Vasquez | 15.00 € | Neutral | 14 Jan 2014 |
| Jaime Vasquez | 16.00 € | Overweight | 1 Nov 2013 |
| Jaime Vasquez | 18.00 € | Overweight | 1 Oct 2013 |
| Jaime Vasquez | 19.00 € | Overweight | 31 Jul 2013 |
| Jaime Vasquez | 20.00 € | Overweight | 24 Apr 2013 |
| Jaime Vasquez | 18.00 € | Overweight | 18 Feb 2013 |
| Jaime Vasquez | 14.93 € | Overweight | 12 Oct 2011 |
| Jaime Vasquez | 13.60 € | Neutral | 12 Aug 2011 |
| Paul Diamond | 12.18 € | Underweight | 19 Jul 2011 |
| Paul Diamond | 8.71 € | Underweight | 1 Dec 2010 |
| Rickin Thakrar | 7.80 € | Overweight | 18 Jan 2010 |
| Rickin Thakrar | 7.40 € | Overweight | 1 Dec 2009 |
| Rickin Thakrar | 7.00 € | Overweight | 27 Oct 2009 |
| Alastair Johnston | 5.50 € | Overweight | 7 May 2009 |
| Alastair Johnston | 4.70 € | Overweight | 18 Feb 2009 |
| Alastair Johnston | 5.80 € | Overweight | 15 Dec 2008 |
| Alastair Johnston | 7.40 € | Overweight | 29 Aug 2008 |
| Alastair Johnston | 7.70 € | Overweight | 8 Aug 2008 |
| Alastair Johnston | 7.00 € | Overweight | 1 Aug 2008 |
| Alastair Johnston | 5.20 € | Overweight | 7 Sep 2007 |
| Alastair Johnston | 5.00 € | Overweight | 27 Jul 2007 |
| Alastair Johnston | 4.80 € | Overweight | 1 Jun 2007 |
| Alastair Johnston | 3.43 € | Overweight | 8 Nov 2006 |
| Alastair Johnston | 3.30 € | Overweight | 20 Oct 2006 |
| Alastair Johnston | 3.10 € | Overweight | 4 May 2006 |
| Alastair Johnston | 2.78 € | Overweight | 16 Jan 2006 |
| Alastair Johnston | 2.60 € | Overweight | 10 Jan 2006 |
The information presented refers to recommendations issued by analysts that follow the Jerónimo Martins share. For more information, please read the Analysts Coverage section in this website’s Terms and Conditions.